Literature DB >> 20543187

Cognitive decline precedes late-life longitudinal changes in vascular risk factors.

Peter van Vliet1, Rudi G J Westendorp, Diana van Heemst, Anton J M de Craen, Anna M Oleksik.   

Abstract

INTRODUCTION: Although obesity, hypercholesterolaemia and hypertension in midlife are risk factors for dementia in late life, dementia is associated with lower body mass index, cholesterol levels and blood pressures. It is unclear whether declines in these vascular risk factors are preceded by declines in cognitive function or vice versa.
METHODS: Within the Leiden 85-plus Study, a prospective population-based study of 599 subjects aged 85 years, the authors annually measured body mass index, total cholesterol, high-density lipoprotein (HDL) cholesterol, glucose levels and blood pressure, and assessed global cognitive function using the Mini Mental State Examination (MMSE) during a 5-year follow-up.
RESULTS: For the whole population who survived up to the age of 90 years, strong annual declines in MMSE score, body mass index, total cholesterol levels, glucose levels, and blood pressure, and an annual increase in HDL cholesterol levels were observed during the follow-up period (all p< or =0.010). Annual changes in MMSE score from age 85 to 87 years were associated positively with annual changes from age 87 to 90 years in total and HDL cholesterol levels (p=0.002 and p=0.013), systolic and diastolic blood pressure (p=0.008 and p=0.048), but not BMI. Parameter value changes from age 85 to 87 years were not associated with changes in MMSE score from age 87 to 90 years. DISCUSSION: In old age, cognitive decline precedes declines in total cholesterol levels, HDL cholesterol levels and blood pressure, and not vice versa. Possibly, brain lesions in metabolic and blood pressure regulation centres cause dysregulation of lipid metabolism and blood pressure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20543187     DOI: 10.1136/jnnp.2009.182519

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus Study.

Authors:  Peter van Vliet; Behnam Sabayan; Liselotte W Wijsman; Rosalinde K E Poortvliet; Simon P Mooijaart; Wouter de Ruijter; Jacobijn Gussekloo; Anton J M de Craen; R G J Westendorp
Journal:  Neurology       Date:  2014-08-20       Impact factor: 9.910

Review 2.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

Review 3.  Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.

Authors:  Kaarin J Anstey; Kimberly Ashby-Mitchell; Ruth Peters
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Longitudinal trajectories of blood lipid levels in an ageing population sample of Russian Western-Siberian urban population.

Authors:  Jaroslav A Hubacek; Yuri Nikitin; Yulia Ragino; Ekaterina Stakhneva; Hynek Pikhart; Anne Peasey; Michael V Holmes; Denes Stefler; Andrey Ryabikov; Eugeny Verevkin; Martin Bobak; Sofia Malyutina
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

5.  Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studies.

Authors:  Somayeh Rostamian; Saskia le Cessie; Koen A Marijt; J Wouter Jukema; Simon P Mooijaart; Mark A van Buchem; Thorbald van Hall; Jacobijn Gussekloo; Stella Trompet
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

Review 6.  Hypertension, brain damage and cognitive decline.

Authors:  Dariusz Gąsecki; Mariusz Kwarciany; Walenty Nyka; Krzysztof Narkiewicz
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.